79
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Oral treatment with the herbal formula B401 protects against aging-dependent neurodegeneration by attenuating oxidative stress and apoptosis in the brain of R6/2 mice

, , , &
Pages 1825-1837 | Published online: 06 Nov 2015

References

  • KumarGPKhanumFNeuroprotective potential of phytochemicalsPharmacogn Rev2012612819023055633
  • The Huntington’s Disease Collaboration GroupA novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomesCell19937269719838458085
  • BanoDZanettiFMendeYNeurodegenerative processes in Huntington’s diseaseCell Death Dis20112e22822071633
  • DaviesSWTurmaineMCozensBAFormation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutationCell19979035375489267033
  • SchillingGBecherMWSharpAHIntranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtinHum Mol Genet1999833974079949199
  • BealMFAging, energy, and oxidative stress in neurodegenerative diseasesAnn Neurol19953833573667668820
  • JenkinsBGKoroshetzWJBealMFEvidence for impairment of energy metabolism in vivo in Huntington’s disease using localized 1H NMR spectroscopyNeurology19934312268926958255479
  • Munoz-SanjuanIBatesGPThe importance of integrating basic and clinical research toward the development of new therapies for Huntington diseaseJ Clin Invest2011121247648321285520
  • WangSELinCLHsuCHTreatment with a herbal formula B401 enhances neuroprotection and angiogenesis in the R6/2 mouse model of Huntington’s diseaseDrug Des Dev Ther20159887900
  • BealMFMitochondria, free radicals and neurodegenerationCurr Opin Neurobiol1996656616668937831
  • Portera-CailliauCHedreenJCPriceDLEvidence for apoptotic cell death in Huntington disease and excitotoxic animal modelsJ Neurosci19955Pt 2377537877751945
  • MangiariniLSathasivamKSellerMExon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic miceCell19968734935068898202
  • ChienCTFanSCLinSCGlucagon-like peptide-1 receptor agonist activation ameliorates venous thrombosis-induced arteriovenous fistula failure in chronic kidney diseaseThromb Haemost201411251051106425030617
  • GutekunstCALiSHYiHNuclear and neuropil aggregates in Huntington’s disease: relationship to neuropathologyJ Neurosci19991972522253410087066
  • ChongZZLiFMaieseKOxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative diseaseProg Neurobiol200575320724615882775
  • HickeyMAChesseletMFApoptosis in Huntington’s diseaseProg Neuropsychopharmacol Biol Psychiatry200327225526512657365
  • ChenXCZhuYGZhuLAGinsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stressEur J Pharmacol200347311712877931
  • YuSLiSYangHA novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discoveryRapid Commun Mass Spectrom200519225025415609367
  • FerranteRJGutekunstCAPersichettiFHeterogeneous topographic and cellular distribution of huntingtin expression in the normal human neostriatumJ Neurosci1997179305230639096140
  • HalliwellBRole of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatmentDrugs Aging200118968571611599635
  • WyttenbachASauvageotOCarmichaelJHeat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtinHum Mol Genet20021191137115111978772
  • RaoRVBredesenDEMisfolded proteins, endoplasmic reticulum stress and neurodegenerationCurr Opin Cell Biol200416665366215530777
  • TattonWGOlanowCWApoptosis in neurodegenerative diseases: the role of mitochondriaBiochim Biophys Acta19991410219521310076027